Aim: Cardiogenic shock is the most serious complication of acute coronary syndromes and cause of death in 4.2-7.2% of patients with acute ST-elevation myocardial infarction (STEMI), in 2.1% of patients with acute non-ST-elevation myocardial infarction and in 2.9% of patients with unstable angina pectoris. The cardiogenic shock mortality rate of 80% in patients treated conservatively has been decreased with the introduction of primary percutaneous coronary intervention (PCI) in the treatment of STEMI. The incidence and mortality rate were assessed in patients with cardiogenic shock treated with primary PCI at Department of Cardiovascular Diseases, Sestre Milosrdnice University Hospital.
Patients And Methods: Since 2000, the emergency interventional cardiologic service has been available for 24 h at the Department. During this period, 701 patients were hospitalized with the diagnosis of STEMI, 312 of them meeting the recommended criteria, were treated with primary PCI.
Results: According to study results, the incidence of cardiogenic shock in STEMI patients was 8.3%. Treatment with primary PCI decreased cardiogenic shock mortality rate to 35%.
Conclusion: Primary PCI is definitely therapy of choice in the treatment of this serious complication of acute STEMI.
Download full-text PDF |
Source |
---|
J Cardiothorac Surg
January 2025
Echocardiography and Vascular Ultrasound Center, The First Affiliated Hospital, Zhejiang University School of Medicine, 79 Qingchun Road, Hangzhou, 310003, China.
Background: Interventricular septal dissection is a critical disease characterized by the separation of the intraventricular septum into two layers, forming an intermediate layer with a cystic cavity that communicates with the root of the aorta or ventricle. It has low morbidity and high mortality rates.
Case Presentation: Case 1: A 58-year-old male with a history of hypertension and smoking presented to a local hospital due to chest tightness and pain for 4 days.
Am J Cardiol
January 2025
Parkland Health System, Dallas, TX; Division of Cardiology, Department of Internal Medicine, University of Texas Southwestern Medical Center, Dallas, TX. Electronic address:
Data regarding cardiogenic shock (CS) from safety-net hospitals serving socioeconomically-disadvantaged patients are limited. In addition, little is known regarding long-term outcomes and management of heart failure-related CS (HF-CS), a population potentially especially vulnerable to adverse social determinants of health (SDOH). A single-center retrospective cohort study of patients with Stage C, D, or E CS at a public safety-net hospital between 2017-2023 was performed.
View Article and Find Full Text PDFAnn Biomed Eng
January 2025
BioCardioLab, Fondazione Toscana G. Monasterio, 54100, Massa, Italy.
Extracorporeal Membrane Oxygenation (ECMO) is a modality of extracorporeal life support which allows temporary support in cases of cardiopulmonary failure and cardiogenic shock. This study presents a valveless pump that works by the Liebau effect as a possible pumping system in ECMO circuits, replacing the current roller and centrifugal pumps. For this purpose, a mock circulatory loop emulating the haemodynamic of the right part of the heart has been constructed.
View Article and Find Full Text PDFIndian Heart J
January 2025
Department of Cardiology, Chest Diseases Hospital, Kuwait. Electronic address:
Industry's influence on clinical trials is well known and extends to various aspects beyond funding, including industry-affiliated authors and industry-affiliated analysts. An area of potential concern is presentation of analyzed data that does not appear favorable to the desired study outcome. Such important data are at times not accorded prominence in discussion.
View Article and Find Full Text PDFRev Esp Anestesiol Reanim (Engl Ed)
January 2025
Departamento de ECMO, Fundación Cardiovascular de Colombia, Floridablanca, Colombia. Electronic address:
Heart failure is a complication that may develop in patients diagnosed with acromegaly. This complication can progress to cardiogenic shock, which in cases like the one described, may be refractory to optimal medical management, necessitating the use of mechanical circulatory support as a bridge to decision. Given the specific morphology of this patient's heart, the likelihood of finding a suitable donor in our environment was very low.
View Article and Find Full Text PDFEnter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!